Harmonized Index of Consumer Prices: Pharmaceutical Products for Euro Area (19 Countries)
CP0611EZ19M086NEST • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
114.91
Year-over-Year Change
1.79%
Date Range
12/1/2000 - 6/1/2025
Summary
The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products in the Euro Area (19 countries) is an important economic indicator that tracks changes in the prices of medications and related healthcare products.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The HICP Pharmaceutical Products index is a key measure of consumer price inflation in the Euro Area, providing insight into the costs of essential healthcare goods. It is closely monitored by policymakers and economists to assess the overall health of the regional economy.
Methodology
The data is collected through surveys of consumer spending and calculated according to harmonized statistical methods across the Eurozone.
Historical Context
This index is a critical input for the European Central Bank's monetary policy decisions.
Key Facts
- The Eurozone HICP for Pharmaceutical Products has a base year of 2015.
- This index tracks prices for a basket of essential medicines and healthcare items.
- Pharmaceutical costs make up around 2% of the total Eurozone consumer price index.
FAQs
Q: What does this economic trend measure?
A: The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products tracks the prices of medications, medical supplies, and other healthcare goods purchased by consumers in the Euro Area.
Q: Why is this trend relevant for users or analysts?
A: This index provides important insights into consumer inflation and the cost of essential healthcare goods, which are crucial factors for policymakers, businesses, and households in the Eurozone.
Q: How is this data collected or calculated?
A: The data is collected through surveys of consumer spending and calculated according to harmonized statistical methods across the 19 countries of the Eurozone.
Q: How is this trend used in economic policy?
A: The Eurozone HICP for Pharmaceutical Products is a key input for the European Central Bank's monetary policy decisions, as it helps assess overall price stability and consumer inflation in the region.
Q: Are there update delays or limitations?
A: The HICP Pharmaceutical Products data is published monthly with a typical delay of around 2-3 weeks. The index may not capture all regional variations in healthcare costs within the Eurozone.
Related Trends
Harmonized Index of Consumer Prices: Passenger Transport by Sea and Inland Waterway for European Union (27 Countries from 2020)
CP0734EU272020M086NEST
Harmonized Index of Consumer Prices: Non-Energy Industrial Goods for Euro Area (19 Countries)
IGDSXEEZ19M086NEST
Inactivity Rate: Aged 15-64: Males for the European Union
LRIN64MAEUQ156S
Import Price Index by Origin (NAICS): Fabricated Metal Product Manufacturing for European Union
COEECZ332
Harmonized Index of Consumer Prices: Beer for European Union (28 Countries)
CP0213EU28M086NEST
Producer Prices Index: Economic activities: Manufacture of food products: Domestic for the European Union
EU28PIEAFD02GPM
Citation
U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for Euro Area (19 Countries) (CP0611EZ19M086NEST), retrieved from FRED.